Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Emvic ApS
APS
Active
CVR 43735217
Hunderupgade 3
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2022
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 124K
-24% vs 2023
EBITDA margin
100.0%
-24% vs 2023
Equity ratio
22.3%
Financial strength
Net profit 2024
DKK 67K
-43% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK 124K
-24%
EBITDA
DKK 124K
-24%
Net profit
DKK 67K
-43%
Total assets
DKK 1M
+286%
Equity
DKK 226K
+42%
Employees
—
—
Company information
Legal name
Emvic ApS
CVR number
43735217
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
22. december 2022
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er B2B af medicinsk udstyr, handel, investering og dermed beslægtet virksomhed
Contact
Address
Hunderupgade 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Odense
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
DKK thousands
Item
2023
2024
Revenue
162
124
Staff expenses
-0
-0
EBITDA
162
124
Depreciation & amort.
-18
-12
EBIT
145
112
Net financials
8
-25
Profit before tax
153
88
Tax
34
20
Net profit
119
67
Balance sheet
DKK thousands
Item
2023
2024
Total assets
263
1.017
Equity
159
226
Long-term debt
0
0
Short-term debt
104
791
Total debt
104
791
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2023
2024
Equity ratio
22.3%
This company
38.2%
Market median
-42% vs market
2023
2024
Return on equity
29.7%
This company
18.4%
Market median
+61% vs market
2023
2024
Net profit margin
54.2%
This company
8.1%
Market median
+569% vs market
2023
2024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
2023
2024
Debt / equity
3.49×
This company
0.62×
Market median
-463% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-12-22 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
EM
Emil Mørk Henningsen
Management
Management
2022
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
LM
Louise Marie Tranberg Fallesen
Board of Directors
2023
—
—
JG
Jane Goldine Pedersen
Board of Directors
2022
—
—
VB
Victoria Burles Piihl
Chairman
2022
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Emil Henningsen Holding 2022 ApS
Company
100.0%
100.0%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Emil Henningsen Holding 2022 ApS
Emvic ApS
(this company)
Apeer Beauty ApS
Board network connections
Board members of Emvic ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Emil Mørk Henningsen
Management
0 companies
Louise Marie Tranberg Fallesen
Board of Directors
0 companies
Jane Goldine Pedersen
Board of Directors
0 companies
Victoria Burles Piihl
Chairman
0 companies